We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$428M 4.02%
2,036,361
-99,894
-5% -$21M
AMGN icon
2
Amgen
AMGN
$198B
$321M 3.01%
1,262,359
+391,069
+45% +$96.9M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.17T
$254M 2.38%
3,463,900
+284,180
+9% +$21.7M
AMZN icon
4
Amazon
AMZN
$2.63T
$244M 2.29%
1,549,840
-66,180
-4% -$10.4M
MRK icon
5
Merck
MRK
$315B
$243M 2.29%
3,075,044
+938,625
+44% +$73.5M
AAPL icon
6
Apple
AAPL
$4.79T
$232M 2.18%
2,003,674
-524,070
-21% -$57.2M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$68.3B
$181M 1.7%
323,036
+94,135
+41% +$57.1M
DHR icon
8
Danaher
DHR
$127B
$164M 1.54%
860,599
+190,247
+28% +$33.8M
TMO icon
9
Thermo Fisher Scientific
TMO
$196B
$154M 1.45%
349,238
+82,897
+31% +$34.2M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$120B
$152M 1.43%
558,131
+11,940
+2% +$3.29M
META icon
11
Meta Platforms (Facebook)
META
$1.59T
$143M 1.34%
546,410
-58,704
-10% -$15.1M
PG icon
12
Procter & Gamble
PG
$347B
$137M 1.29%
985,926
+126,567
+15% +$16.8M
BABA icon
13
Alibaba
BABA
$279B
$132M 1.24%
449,711
+119,865
+36% +$31.6M
GILD icon
14
Gilead Sciences
GILD
$162B
$122M 1.14%
1,925,790
+235,765
+14% +$16.3M
PYPL icon
15
PayPal
PYPL
$49B
$105M 0.99%
534,237
-85,166
-14% -$16M
BIIB icon
16
Biogen
BIIB
$29.2B
$104M 0.98%
367,589
+26,670
+8% +$7.44M
BMY icon
17
Bristol-Myers Squibb
BMY
$124B
$102M 0.96%
1,694,526
+189,488
+13% +$11.4M
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$101M 0.95%
517,099
+126,180
+32% +$21.1M
ILMN icon
19
Illumina
ILMN
$28.9B
$92M 0.86%
305,914
+117,237
+62% +$40.4M
QCOM icon
20
Qualcomm
QCOM
$185B
$77.7M 0.73%
660,407
+282,403
+75% +$30.2M
NVDA icon
21
NVIDIA
NVDA
$5.14T
$75.1M 0.71%
5,550,200
-367,000
-6% -$4.27M
TSM icon
22
TSMC
TSM
$2.18T
$73.1M 0.69%
901,821
-216,113
-19% -$16.4M
GOOG icon
23
Alphabet (Google) Class C
GOOG
$4.17T
$72.6M 0.68%
987,660
+71,480
+8% +$5.45M
DIS icon
24
Walt Disney
DIS
$166B
$70.1M 0.66%
564,832
-22,951
-4% -$2.87M
V icon
25
Visa
V
$672B
$69.5M 0.65%
347,632
-31,433
-8% -$6.28M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.